top of page

Cancer Genomics Testing



Common Drug Targets *



 Pegylated Interferon


*Note: Drugs listed above are not an all encompassing list 

Cancer Genomics (CGx)

Why Cancer Genomics?


What if there was a way to screen for hereditary cancer types?  QTLD's Cancer Genomics panel delivers a comprehensive report on how genetics can impact the patient's response to specific medications.  Our diagnostic comprehensive PGx panel can help a provider customize medication plans to a specific patient's genetic makeup.  Ultimately, this can help reduce patient hospitalizations from adverse drug reactions.  

Understand Your Patient's Drug Sensitivity


Pharmacogenomics can help determine if a patient is metabolizing medication at a high, moderate, or low rate. 

    Low Metabolism: PGx can help REDUCE Adverse Drug Reactions from Toxicity - Excessive amounts of medications can accumulate in bloodstream lead to an adverse drug reaction.
    Moderate to High Metabolism: PGx can help UNDERSTAND if the patient is not absorbing their medication in the bloodstream at a rate which leads to a therapeutic effect.  
    PGx helps providers identify patients with a possible hypersensitive response to normal amounts of prescribed medication  which can help reduce adverse drug reactions before giving the patient a customized medication plan.


Our Offering & Key Benefits


   Robust panel with 30+ genes
   Created for providers to better understand their patient before prescribing medication.
    PGx leads to evidence based, actionable genetic data 
          •    One-Time Genetic Test for Each Patient

          •    Lower Healthcare Costs and Improve Outcomes
          •    Genetic Data Adds a Personalized Experience for Your Patients

Our “Priority + Program”


   Open saturdays & emergency hours
   Dedicated patient hotline for all EOB/billing questions
   Internal FTE’s (at lab) for office/facility support
   Best-in-Class LIMS system 
   No cost for EMR integration

bottom of page